The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.
Shares of Thermo Fisher Scientific Inc. TMO rose 1.10% to $528.96 Friday, on what proved to be an all-around positive trading ...
We recently published a list of 10 Best Affordable Dividend Stocks to Buy According to Hedge Funds. In this article, we are ...
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
Swiss public transport company, Regionalverkehr Bern-Solothurn (RBS), made its debut in the public market on Thursday. The ...
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Weitz Investment Management, an investment management firm, released its “Partners III Opportunity Fund” fourth-quarter 2024 ...
Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus Registry to advance lupus research. The ...
In 2023, the market has already surpassed USD 1,716.5 million, reflecting its steady expansion. Among the key contributors, diagnostic laboratories account for over 51.8% of the market share, ...
This useful study presents findings on the developmental roles of Nup107, a key nucleoporin, in regulating the larval-to-pupal transition in Drosophila melanogaster through its involvement in ecdysone ...
Shares of Thermo Fisher Scientific Inc. TMO shed 1.89% to $523.23 Thursday, on what proved to be an all-around rough trading ...
Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that the company has entered into a definitive agreement with Solventum to acquire Solventum’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results